Centessa Pharmaceuticals PLC - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Centessa Pharmaceuticals PLC - ADR
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
/ 
Frequently asked questions
To buy Centessa Pharmaceuticals PLC - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Centessa Pharmaceuticals PLC - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Centessa Pharmaceuticals PLC - ADR is CNTA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Centessa Pharmaceuticals PLC - ADR has its primary listing on NASDAQ. You can trade Centessa Pharmaceuticals PLC - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Centessa Pharmaceuticals PLC - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Centessa Pharmaceuticals PLC - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Centessa Pharmaceuticals PLC - ADR.